bioXXmed AG (FRA:T5O)

Germany flag Germany · Delayed Price · Currency is EUR
0.8700
+0.0400 (4.82%)
Last updated: Aug 3, 2026, 11:31 AM CET
Market Cap236.52K +119.2%
Revenue (ttm)16.73K +379.0%
Net Income-365.39K
EPS-1.34
Shares Out 271.87K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4
Open0.8700
Previous Close0.8300
Day's Range0.8700 - 0.8700
52-Week Range0.0050 - 2.7500
Beta5.01
Analystsn/a
Price Targetn/a
Earnings DateJul 3, 2026

About bioXXmed AG

bioXXmed AG, a holding company, investing in biotechnology and medical technology companies. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol T5O
Full Company Profile

Financial Performance

In 2025, bioXXmed AG's revenue was 16,731, an increase of 378.99% compared to the previous year's 3,493. Losses were -365,390, -63.35% less than in 2024.

Financial Statements